Levopropoxyphene
From Self-sufficiency
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
| Levopropoxyphene | |
|---|---|
| File:Levopropoxyphene.png | |
| (1R,2S)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate | |
| Other names [(2R,3S)-4-dimethylamino-3-methyl-1,2-diphenyl-butan-2-yl]propanoate | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
| CAS number | 2338-37-6 |
| PubChem | 200742 |
| SMILES | Script error: No such module "collapsible list". |
| style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
| Molecular formula | C22H29NO2 |
| Molar mass | 339.47 g mol−1 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
Levopropoxyphene is an antitussive. It is an optical isomer of dextropropoxyphene. The racemic mixture is called propoxyphene. Only the dextro-isomer (dextropropoxyphene) has an analgesic effect; the levo-isomer appears to exert only an antitussive effect. It was formerly marketed in the U.S. by Eli Lilly under the tradename Novrad as an antitussive.
| 45px | This drug article relating to the respiratory system is a stub. You can help ssf by expanding it. |
